Corporate Mission

XORTX Pharma Corp., we are dedicated to developing therapeutics to treat cardio-vascular disease, where few or no drugs are approved. Our company is focused on a treatment to slow or stop progressive kidney disease in two areas:  autosomal dominant polycystic kidney disease (ADPKD) a rare kidney disease, and diabetic nephropathy. Our dedication to lead and advance therapies, in these fields and thereby improving the quality of life and future health of millions of patients is our inspiration.